(Q35064432)

6 August 2017

1 reference

title

Neoral monitoring 2 hours post-dose and the pediatric transplant patient (English)

1 reference

6 August 2017

Stephen P Dunn

1

1 reference

6 August 2017

publication date

1 February 2003

1 reference

Pediatric Transplantation

6 August 2017

published in

1 reference

6 August 2017

volume

7

1 reference

6 August 2017

issue

1

1 reference

6 August 2017

page(s)

25-30

1 reference

Influence of cyclosporine pharmacokinetics, trough concentrations, and AUC monitoring on outcome after kidney transplantation.

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.2003.02040.X

Cyclosporin A in patients receiving renal allografts from cadaver donors

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.2003.02040.X

7 January 2021

Improved graft survival after renal transplantation in the United States, 1988 to 1996

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.2003.02040.X

7 January 2021

https://api.crossref.org/works/10.1034%2FJ.1399-3046.2003.02040.X

1 reference

7 January 2021

The temporal profile of calcineurin inhibition by cyclosporine in vivo

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.2003.02040.X

7 January 2021

C2 monitoring strategy for optimising cyclosporin immunosuppression from the Neoral formulation

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.2003.02040.X

7 January 2021

Impact of absorption profiling on efficacy and safety of cyclosporin therapy in transplant recipients.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.2003.02040.X

7 January 2021

Absorption profiling of cyclosporine microemulsion (neoral) during the first 2 weeks after renal transplantation

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.2003.02040.X

7 January 2021

Variable oral absorption of cyclosporine. A biopharmaceutical risk factor for chronic renal allograft rejection

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.2003.02040.X

7 January 2021

Pharmacokinetics of an oral solution of the microemulsion formulation of cyclosporine in maintenance pediatric liver transplant recipients

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.2003.02040.X

7 January 2021

Absorption characteristics of a microemulsion formulation of cyclosporine in de novo pediatric liver transplant recipients

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.2003.02040.X

7 January 2021

Peak cyclosporine levels (Cmax) correlate with freedom from liver graft rejection: results of a prospective, randomized comparison of neoral and sandimmune for liver transplantation (NOF-8)

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.2003.02040.X

7 January 2021

Stimulated response of peripheral lymphocytes may distinguish cyclosporine effect in renal transplant recipients receiving a cyclosporine+rapamycin regimen

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.2003.02040.X

7 January 2021

Determinants of long-term survival of pediatric kidney grafts reported to the United Network for Organ Sharing kidney transplant registry

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.2003.02040.X

7 January 2021

Improved cadaveric renal transplant outcome in children

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.2003.02040.X

7 January 2021

Cyclosporin pharmacokinetics in paediatric transplant recipients

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.2003.02040.X

7 January 2021

Small-bowel length and the dose of cyclosporine in children after liver transplantation

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.2003.02040.X

7 January 2021

Refining immunosuppressive protocols in pediatric renal transplant recipients

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.2003.02040.X

7 January 2021

Abbreviated cyclosporine AUCs on Neoral--the search continues!

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.2003.02040.X

7 January 2021

Sandimmune to Neoral conversion and value of abbreviated AUC monitoring in stable pediatric kidney transplant recipients

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.2003.02040.X

7 January 2021

Cyclosporine peak concentration in relation to the four-hour absorption phase in pediatric renal graft recipients

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.2003.02040.X

7 January 2021

Cyclosporine A monitoring in children: abbreviated area under curve formulas and C2 level

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.2003.02040.X

7 January 2021

Neoral C(2) monitoring in pediatric liver transplant recipients

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.2003.02040.X

7 January 2021

10.1034/J.1399-3046.2003.02040.X

Identifiers

DOI

1 reference

6 August 2017

1 reference